The presence of a systemic inflammatory response syndrome, with modification of inflammatory markers (elevation of C-reactive protein, progressive leucocytosis or positive blood cultures) and the onset of clinical deterioration in a stable patient on adequate support, with new or prolonged organ failure, are suggestive for IPN in 80% of cases [46, 47]. This evidence concerns the gene CRP and systemic inflammatory response syndrome.